Genetically Targeted T Cells Eradicate Systemic Acute Lymphoblastic Leukemia Xenografts

Both in vivo costimulation and repeated administration enhance eradication of systemic tumor by genetically targeted T cells. The finding that modifications in CAR design as well as T-cell dosing allowed for the complete eradication of systemic disease affects the design of clinical trials using this treatment strategy.